• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

非 HIV 免疫功能健全的 COVID-19 患者合并严重肺孢子菌肺炎感染。

Non-HIV Immunocompetent Patient with COVID-19 and Severe Pneumocystis jirovecii Pneumonia Co-Infection.

出版信息

Emerg Infect Dis. 2024 Sep;30(9):1948-1952. doi: 10.3201/eid3009.240615.

DOI:10.3201/eid3009.240615
PMID:39174035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11346996/
Abstract

Pneumocystis jirovecii pneumonia is an opportunistic infection that affects HIV-infected and immunocompromised persons and rarely affects immunocompetent patients. However, after the advent of the COVID-19 pandemic, some COVID-19 patients without immunocompromise or HIV were infected with P. jirovecii. Clinical manifestations were atypical, easily misdiagnosed, and rapidly progressive, and the prognosis was poor.

摘要

肺孢子菌肺炎是一种机会性感染，影响 HIV 感染者和免疫功能低下者，很少影响免疫功能正常的患者。然而，在 COVID-19 大流行出现后，一些没有免疫抑制或 HIV 的 COVID-19 患者感染了肺孢子菌。临床表现不典型，容易误诊，病情进展迅速，预后不良。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/7a7e792e0b74/24-0615-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/2f475397ba89/24-0615-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/d9fc5287bc6c/24-0615-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/1227d33c5b7e/24-0615-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/7a7e792e0b74/24-0615-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/2f475397ba89/24-0615-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/d9fc5287bc6c/24-0615-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/1227d33c5b7e/24-0615-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2cb/11346996/7a7e792e0b74/24-0615-F4.jpg

相似文献

1
Non-HIV Immunocompetent Patient with COVID-19 and Severe Pneumocystis jirovecii Pneumonia Co-Infection.非 HIV 免疫功能健全的 COVID-19 患者合并严重肺孢子菌肺炎感染。
Emerg Infect Dis. 2024 Sep;30(9):1948-1952. doi: 10.3201/eid3009.240615.
2
Pneumocystis jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection.一名新诊断为HIV-1感染患者的耶氏肺孢子菌肺炎与严重急性呼吸综合征冠状病毒2合并感染
Clin Infect Dis. 2021 Apr 26;72(8):1487-1489. doi: 10.1093/cid/ciaa906.
3
Pneumocystis pneumonia in the COVID-19 pandemic era: similarities and challenges.COVID-19 大流行时代的肺孢子菌肺炎：相似性与挑战。
Trends Parasitol. 2021 Oct;37(10):859-862. doi: 10.1016/j.pt.2021.07.010. Epub 2021 Aug 4.
4
Coinfection with Mycobacterium tuberculosis and Pneumocystis Jirovecii in immunocompetent young woman.免疫功能正常的年轻女性同时感染结核分枝杆菌和耶氏肺孢子菌。
Arch Inst Pasteur Tunis. 2013;90(1-4):55-60.
5
Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient.一名25岁严重免疫功能低下患者同时感染新冠病毒和耶氏肺孢子菌肺炎。
Int J Infect Dis. 2020 Oct;99:119-121. doi: 10.1016/j.ijid.2020.07.061. Epub 2020 Aug 5.
6
[Simultaneous diagnosis and favorable evolution of infection with Pneumocystis jirovecii, SARS-CoV-2 and advanced HIV].[耶氏肺孢子菌、SARS-CoV-2感染与晚期HIV感染的同时诊断及良好转归]
Medicina (B Aires). 2020;80(5):554-556.
7
pneumonia in an immunocompetent patient recovered from COVID-19.新冠肺炎康复后免疫功能正常患者的肺炎。
Infect Dis (Lond). 2021 May;53(5):382-385. doi: 10.1080/23744235.2021.1890331. Epub 2021 Mar 1.
8
Pneumocystis jirovecii and SARS-CoV-2 Coinfection as Presentation of X-linked Severe Combined Immunodeficiency.耶氏肺孢子菌与严重急性呼吸综合征冠状病毒2型合并感染作为X连锁严重联合免疫缺陷病的表现
Indian J Pediatr. 2023 Aug;90(8):832-833. doi: 10.1007/s12098-023-04661-2. Epub 2023 May 30.
9
A comprehensive clinical guide for pneumonia: a missing therapeutic target in HIV-uninfected patients.肺炎综合临床指南：HIV 阴性患者的治疗靶点缺失
Expert Rev Respir Med. 2022 Nov-Dec;16(11-12):1167-1190. doi: 10.1080/17476348.2022.2152332. Epub 2022 Dec 12.
10
The first detection of Pneumocystis jirovecii in asthmatic patients post-COVID-19 in Jordan.约旦首例 COVID-19 后哮喘患者肺孢子菌的检测。
Bosn J Basic Med Sci. 2022 Sep 16;22(5):784-790. doi: 10.17305/bjbms.2022.7335.

本文引用的文献

1
Prevalence of Colonization in Non-Critical Immunocompetent COVID-19 Patients: A Single-Center Prospective Study (JiroCOVID Study).非重症免疫功能正常的COVID-19患者的定植率：一项单中心前瞻性研究（JiroCOVID研究）。
Microorganisms. 2023 Nov 22;11(12):2839. doi: 10.3390/microorganisms11122839.
2
Changing Trends in the Incidence and Clinical Features of Pneumonia in Non-HIV Patients before and during the COVID-19 Era and Risk Factors for Mortality between 2016 and 2022.2016年至2022年间，非HIV患者在COVID-19大流行之前和期间肺炎发病率及临床特征的变化趋势以及死亡风险因素
Life (Basel). 2023 Jun 7;13(6):1335. doi: 10.3390/life13061335.
3
Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience.
非 HIV 患者在 COVID-19 康复后的肺炎：单中心经验。
Int J Environ Res Public Health. 2021 Oct 29;18(21):11399. doi: 10.3390/ijerph182111399.
4
Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.SARS-CoV-2 与其他病原体合并感染和继发感染的流行率和结局：系统评价和荟萃分析。
PLoS One. 2021 May 6;16(5):e0251170. doi: 10.1371/journal.pone.0251170. eCollection 2021.
5
COVID-19 and Pulmonary Coinfection-The First Case Confirmed through Autopsy.COVID-19 与肺部合并感染——首例经尸检确认的病例。
Medicina (Kaunas). 2021 Mar 24;57(4):302. doi: 10.3390/medicina57040302.
6
State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.COVID-19 肺炎患者继发肺部感染的研究进展。
Infection. 2021 Aug;49(4):591-605. doi: 10.1007/s15010-021-01602-z. Epub 2021 Mar 11.
7
Pneumonia: Immunity, Vaccines, and Treatments.肺炎：免疫、疫苗与治疗
Pathogens. 2021 Feb 19;10(2):236. doi: 10.3390/pathogens10020236.
8
Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.血清（1-3）-β-D-葡聚糖检测对肺孢子菌肺炎的诊断准确性：系统评价和荟萃分析。
Clin Microbiol Infect. 2020 Sep;26(9):1137-1143. doi: 10.1016/j.cmi.2020.05.024. Epub 2020 May 30.
9
Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.HIV 感染与非 HIV 感染免疫功能低下患者肺部卡氏肺孢子菌肺炎的临床、诊断和治疗差异。
Respiration. 2018;96(1):52-65. doi: 10.1159/000487713. Epub 2018 Apr 10.
10
[Clinical features of acute respiratory failure due to pneumocystis pneumonia in non-HIV immunocompromised patients].[非HIV免疫功能低下患者肺孢子菌肺炎所致急性呼吸衰竭的临床特征]
Zhonghua Yi Xue Za Zhi. 2016 Oct 18;96(38):3057-3061. doi: 10.3760/cma.j.issn.0376-2491.2016.38.005.